Liver failure treatment MARS: does it help avoid transplants?
NCT ID NCT05594953
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked back at the medical records of 27 patients with alcoholic hepatitis or sudden liver failure who received a treatment called MARS (a type of dialysis that cleans the blood). The goal was to see if MARS helped them survive without needing a liver transplant. Researchers also checked if it improved other problems like brain confusion and time spent in the hospital.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antioxidant rescue failing livers?
- Cow's first milk could be a lifeline for severe Alcohol-Related hepatitis
- Scientists hunt for clues in body fluids to predict liver failure outcomes
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Can a text-and-therapy program keep liver transplant patients sober?
- Zambia study tracks hepatitis b outcomes in hundreds of patients